Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Deals
Features
News
Region
Sectors
Size
Uncategorised

Series B

XpectVision meets series B expectations
CAS-backed X-ray technology developer XpectVision Technology has added $14.2m to its coffers to drive the development of its mammography device.
Landos lands $60m
Osage University Partners is among the series B investors backing Virginia Tech-linked IBD therapy disease developer Landos Biopharma, which is preparing phase 2 trials.
Glycomine digs up $33m series B
Mission Bay Capital has backed a series B round for orphan diseases drug developer Glycomine, which also attracted Novo, Asahi Kasei Pharma and Chiesi.
HawkEye 360 beams in $70m
Allied Minds has returned again for a series B round that took the firm's geospatial data analytics technology subsidiary's total funding to about $96m.
Daily deal net, August 2 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
PredictImmune foresees series B
PredictImmune, a Cambridge spinout, added series B capital from investors including Cambridge Enterprise and CIC to $6.1m in series A funding raised last April.
TScan takes in $48m
Harvard Medical School spinout TScan has come out of stealth with $48m in funding provided by investors including GV and two Novartis units.
CTT taps $10m
Cambridge-founded touchscreen sensor manufacturer CTT has added $10m from investors including chemicals firm Kureha to its coffers.

Other News

Bolt puts $68m in its basket
A host of individuals connected with the e-commerce industry have supplied capital, enabling Stanford-linked company Bolt to target its next phase of expansion.
PlanetIQ observes $18.7m
VTC Innovation Fund contributed to a series B round for weather forecasting satellite constellation developer PlanetIQ, with the cash set to help it launch 20 microsatellites by 2021.
Biontech completes $325m series B
Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.
Daily deal net: June 28, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Axial Biotherapeutics realigns series B
Taiho Ventures has supplied a $10m extension for Caltech spinout Axial Biotherapeutics’ series B, bringing the total to $35m.
Daily deal net: June 19, 2019
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg

Login